The group is continuing the modulated radiotherapy (MRT) programme in paediatric, gynaecological and gastrointestinal tumours. It is currently developing an extracranial stereotactic radiation therapy programme for pancreatic and lung cancer, and lung, liver and bone metastasis.

At the same time, the group is working on improving quality control programmes and developing new techniques. It is also studying new therapeutic combinations with radiation therapy and EGFR inhibitors in head and neck cancer and gastrointestinal tumours.

Visit the research group’s page


Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.